Back
XTL Biopharmaceuticals 10K Form
Sell
37
XTLB
XTL Biopharmaceuticals
Last Price:
2.20
Seasonality Move:
0.88%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive XTLB News And Ratings
See the #1 stock for the next 7 days that we like better than XTLB
XTLB Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $0 |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.50 |
| Price / Book: | 4.5 |
Profitability
| EPS (TTM): | -0.03130 |
|---|---|
| Net Income (TTM): | $-378K |
| Gross Margin: | $0 |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
XTL Biopharmaceuticals Earnings Forecast
Key XTL Biopharmaceuticals Financial Ratios
- The Interest Expense is 0.00% of Operating Income.
- Per Share Earnings over the last 23 years have been positive in 10 years.
XTL Biopharmaceuticals Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | XTLB |
| CUSIP: | 98386D |
| Website: | xtlbio.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
XTLB Technical Analysis vs Fundamental Analysis
Sell
37
XTL Biopharmaceuticals (XTLB)
is a Sell
Is XTL Biopharmaceuticals a Buy or a Sell?
-
XTL Biopharmaceuticals stock is rated a Sell
The current XTL Biopharmaceuticals [XTLB] share price is $2.22. The Score for XTLB is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.